Pajvani UB - Search Results

1

Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction-associated steatohepatitis.

Steffani M, Geng Y, Pajvani UB, Schwabe RF. Steffani M, et al. Among authors: pajvani ub. J Clin Invest. 2024 Apr 1;134(7):e179710. doi: 10.1172/JCI179710. J Clin Invest. 2024. PMID: 38557494 Free PMC article.

2

Diabetes mellitus-Progress and opportunities in the evolving epidemic.

Abel ED, Gloyn AL, Evans-Molina C, Joseph JJ, Misra S, Pajvani UB, Simcox J, Susztak K, Drucker DJ. Abel ED, et al. Among authors: pajvani ub. Cell. 2024 Jul 25;187(15):3789-3820. doi: 10.1016/j.cell.2024.06.029. Cell. 2024. PMID: 39059357 Review.

3

Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells.

Prasad K, Bhattacharya D, Shams SGE, Izarraras K, Hart T, Mayfield B, Blaszczyk MB, Zhou Z, Pajvani UB, Friedman SL, Bhattacharya M. Prasad K, et al. Among authors: pajvani ub. Cells. 2024 Oct 4;13(19):1651. doi: 10.3390/cells13191651. Cells. 2024. PMID: 39404414 Free PMC article.

4

KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression.

Jung YH, Lee YJ, Dao T, Jung KH, Yu J, Oh AR, Jeong Y, Gi H, Kim YU, Ryu D, Carrer M, Pajvani UB, Lee SB, Hong SS, Kim K. Jung YH, et al. Among authors: pajvani ub. Clin Mol Hepatol. 2024 Oct;30(4):895-913. doi: 10.3350/cmh.2024.0364. Epub 2024 Aug 5. Clin Mol Hepatol. 2024. PMID: 39098817 Free PMC article.

5

The first MASH drug therapy on the horizon: Current perspectives of resmetirom.

Petta S, Targher G, Romeo S, Pajvani UB, Zheng MH, Aghemo A, Valenti LVC. Petta S, et al. Among authors: pajvani ub. Liver Int. 2024 Jul;44(7):1526-1536. doi: 10.1111/liv.15930. Epub 2024 Apr 5. Liver Int. 2024. PMID: 38578141 Free article. Review.

6

β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese mice.

Suda N, Bartolomé A, Liang J, Son J, Yagishita Y, Siebel C, Accili D, Ding H, Pajvani UB. Suda N, et al. Among authors: pajvani ub. Mol Metab. 2024 Mar;81:101894. doi: 10.1016/j.molmet.2024.101894. Epub 2024 Feb 3. Mol Metab. 2024. PMID: 38311286 Free PMC article.

7

Author Correction: Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner.

Pajvani UB, Shawber CJ, Samuel VT, Birkenfeld AL, Shulman GI, Kitajewski J, Accili D. Pajvani UB, et al. Nat Med. 2024 Feb;30(2):604. doi: 10.1038/s41591-023-02695-9. Nat Med. 2024. PMID: 38041001 No abstract available.

8

Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma.

Yu J, Pajvani UB. Yu J, et al. Among authors: pajvani ub. Med Rev (2021). 2023 Jan 6;2(6):544-546. doi: 10.1515/mr-2022-0043. eCollection 2022 Dec. Med Rev (2021). 2023. PMID: 37724256 Free PMC article.

9

Liver insulinization as a driver of triglyceride dysmetabolism.

Cook JR, Hawkins MA, Pajvani UB. Cook JR, et al. Among authors: pajvani ub. Nat Metab. 2023 Jul;5(7):1101-1110. doi: 10.1038/s42255-023-00843-6. Epub 2023 Jul 17. Nat Metab. 2023. PMID: 37460842 Review.

10

Acetylation of PPARγ in macrophages promotes visceral fat degeneration in obesity.

Aaron N, Zahr T, He Y, Yu L, Mayfield B, Pajvani UB, Qiang L. Aaron N, et al. Among authors: pajvani ub. Life Metab. 2022 Dec;1(3):258-269. doi: 10.1093/lifemeta/loac032. Epub 2022 Nov 11. Life Metab. 2022. PMID: 37213714 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters